Expression of Karyopherin Alpha 2 and Karyopherin Beta 1 Correlate with Poor Prognosis in Gastric Cancer
Open Access
- 21 October 2022
- journal article
- research article
- Published by S. Karger AG in Oncology
- Vol. 100 (12), 685-695
- https://doi.org/10.1159/000526807
Abstract
Introduction: Karyopherin alfa 2 (KPNA2) and karyopherin beta 1 (KPNB1), constitute nuclear transport protein complexes involved in nuclear import, and are significant in tumor progression. Although high KPNA2 expression was associated with poor prognosis in solid tumors, the relationship between KPNA2 and KPNB1 expression and their prognostic role in gastric cancer (GC) remains unclear. Methods: Immunohistochemistry was used to correlate the expression of KPNA2 and KPNB1 with various features, including clinicopathologic characteristics in 130 patients with GC and survival in 94 patients with invasive lesions extending to the submucosa or deeper. Results: High expression of KPNA2 and KPNB1 was found in 25% and 36% of the patients, respectively. Both were significantly related to tumor depth, lymph node metastasis, lymphatic invasion, venous invasion, and Ki-67 expression. KPNA2 expression was significantly related to that of KPNB1 (P < 0.001). Patients with high KPNB1 expression had poorer prognosis than those with low expression (P = 0.027), as was also observed in case of KPNA2 (P < 0.001). Patients with high expression of both KPNA2 and KPNB1 accounted for 18% and had a poorer prognosis than those with high expression of either and those with low expression of both (P = 0.001). Multivariate analysis revealed that high expression of both KPNA2 and KPNB1 was an independent prognostic factor in patients with GC (HR 3.46, 95% CI 1.64–2.73, P = 0.001). Conclusion: KPNA2 expression was correlated with KPNB1 expression, and high co-expression of KPNA2 and KPNB1 may represent a strong prognostic biomarker in GC.Keywords
This publication has 37 references indexed in Scilit:
- Downregulation of KPNA2 in non-small-cell lung cancer is associated with Oct4 expressionJournal of Translational Medicine, 2013
- Overexpression of Kpnβ1 and Kpnα2 Importin Proteins in Cancer Derives from Deregulated E2F ActivityPLOS ONE, 2011
- Nuclear import by karyopherin-βs: Recognition and inhibitionBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2011
- KPNA2 Expression Is an Independent Adverse Predictor of Biochemical Recurrence after Radical ProstatectomyClinical Cancer Research, 2011
- Overexpression of Karyopherin-2 in Epithelial Ovarian Cancer and Correlation With Poor PrognosisObstetrics & Gynecology, 2010
- Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trialThe Lancet, 2010
- The Karyopherin proteins, Crm1 and Karyopherin β1, are overexpressed in cervical cancer and are critical for cancer cell survival and proliferationInternational Journal of Cancer, 2009
- Nuclear karyopherin α2 expression predicts poor survival in patients with advanced breast cancer irrespective of treatment intensityInternational Journal of Cancer, 2008
- Molecular mechanism of the nuclear protein import cycleNature Reviews Molecular Cell Biology, 2007
- Molecular Profiling of Laser-Microdissected Matched Tumor and Normal Breast Tissue Identifies Karyopherin α2 as a Potential Novel Prognostic Marker in Breast CancerClinical Cancer Research, 2006